Last reviewed · How we verify
NCT03876392
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NA trial testing magnetic resonance imaging in Bone Marrow Metastases in 50 participants. Status unknown.
1 December 2022
Quick facts
| Lead sponsor | Shanghai 6th People's Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 50 |
| Start date | 10 May 2019 |
| Primary completion | 1 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- magnetic resonance imaging
Conditions studied
- Bone Marrow Metastases — all drugs for Bone Marrow Metastases →
- Magnetic Resonance Imaging — all drugs for Magnetic Resonance Imaging →
Sponsor
Shanghai 6th People's Hospital
Who can join
Adults 18 to 75, any sex, with Bone Marrow Metastases or Magnetic Resonance Imaging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to study the value and feasibility of magnetic resonance imaging in detection of bone marrow metastases
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03876392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of magnetic resonance imaging
Trials testing the same drug.
- NCT06362330 — Multi-parametric MRI in Patients of Bladder Cancer · recruiting
- NCT05246241 — Preoperative Magnetic Resonance Imaging Abnormalities Predictive of Lumbar Herniation Recurrence · completed
- NCT06849063 — Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE · recruiting
- NCT06526442 — MRE for Diagnosis of Pancreatic Masses · recruiting
- NCT04409457 — Self-Control in Bulimia Nervosa · NA · completed
Other Shanghai 6th People's Hospital trials
Trials by the same sponsor.
- NCT07482891 — An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing · Phase 4 · not yet recruiting
- NCT07414277 — CGM for Insulin-Treated T2DM During Post-Discharge Transition · NA · not yet recruiting
- NCT07359053 — MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma · Phase 2 · recruiting
- NCT07288372 — The CGM-OGTT Glycemic Homeostasis Study · not yet recruiting
- NCT06936657 — Intervention Effects of Optimized Carbohydrate Diet in Patients With Type 2 Diabetes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03876392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai 6th People's Hospital
- Last refreshed: 12 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03876392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing